Premixed vs Basal Bolus Insulin Therapy in Older Patients With Type 2 Diabetes

• Status: Completed
• Trial end date: 2018-06-19
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare efficacy and security of premixed insulin treatment vs basal bolus insulin treatment in older patients with poorly controlled type 2 diabetes.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Consorci Sanitari Integral
• Treatments: Insulin; Insulin, Globin Zinc

Criteria

Inclusion Criteria:

• Outpatients

• Age ≥ 65 years old

• Type 2 diabetes mellitus

• HbA1c ≥9% (74 mmol/mol)

• Previously treated with one or two doses of basal insulin and oral hypoglycaemic agents

Exclusion Criteria:

• Severe insulin-resistance

• High doses of corticosteroids

• Chemotherapy treatment

• High comorbidity

• Bad compliance of the treatment

• Frequent severe hypoglycaemia